Manufacturing Capability
Servatus Ltd is an Australian-owned biopharmaceutical company devoted to creating safe, effective, and reliable microbiome-based therapeutic drugs to treat several chronic and debilitating autoimmune diseases, as well as non-antibiotic treatments for bacterial infections. For more information on this and our clinical trials see: ‘our research’ page.
In addition to our innovative drug research and development, and ongoing clinical trials, Servatus Ltd also owns a state-of-the-art production facility.
Our own production facility means that Servatus are able to oversee all aspects of the research development and production pipeline and ensure that our live biotherapeutic drug candidates (LBPs) are made to our high-standard and specifications, and removes the logistical uncertainty often associated with outsourcing manufacturing.